Curative Biotechnology (Curative Biotechnology) Total Stockholders Equity : $-17.91 Mil (As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology Total Stockholders Equity?

Curative Biotechnology's Total Stockholders Equity for the quarter that ended in Mar. 2023 was $-17.91 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Curative Biotechnology's Book Value per Share for the quarter that ended in Mar. 2023 was $-0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Curative Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2023 was -0.08.

Curative Biotechnology Total Stockholders Equity Historical Data

The historical data trend for Curative Biotechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology Total Stockholders Equity Chart

Curative Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-0.69

-0.36

-4.52

-16.36

-20.53

Curative Biotechnology Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Stockholders Equity	Get a 7-Day Free Trial															-16.69	-17.98	-19.12	-20.53	-17.91

Curative Biotechnology (OTCPK:CUBT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Curative Biotechnology's Book Value per Share for the quarter that ended in Mar. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-17.912	-	0)	/	628.923
	=	-0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Curative Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.369	+	0)	/	-17.912
	=	-0.08

Curative Biotechnology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Curative Biotechnology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biotechnology (Curative Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431

Website

https://www.curativebiotech.com

Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.